2562-68-7 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 20 carbon (C) atoms, 16 hydrogen (H) atoms, 2 nitrogen (N) atoms, and 2 oxygen (O) atoms.
Explanation
The compound is a derivative of the benzimidazole ring, which is a heterocyclic aromatic organic compound containing nitrogen.
Explanation
The compound has a benzimidazole ring, which is a type of heterocyclic aromatic compound with a fused six-membered benzene ring and a five-membered imidazole ring.
Explanation
The benzimidazole ring in this compound has two substituents attached to it a 3,4-dimethoxyphenyl group and a phenyl group.
Explanation
The compound is used in various research and industrial applications, including the development of pharmaceuticals, agrochemicals, and materials science.
Explanation
Due to its structural properties, the compound may have potential therapeutic uses, and it is currently the subject of ongoing scientific study and research.
Explanation
The material provided does not give information about the chemical stability of the compound. Further research would be needed to determine its stability under various conditions.
Explanation
The material provided does not mention the solubility of the compound in different solvents. Solubility can be an important factor in determining its applications and reactivity.
Explanation
The material provided does not provide information about the reactivity of the compound with other chemicals. Further research would be needed to understand its reactivity profile.
Explanation
The material provided does not discuss the toxicity of the compound. Further research would be needed to determine its potential hazards and safety precautions.
Structure
1H-Benzimidazole derivative
Heterocyclic Aromatic Compound
Contains a benzimidazole ring
Substituents
3,4-Dimethoxyphenyl and phenyl groups
Applications
Pharmaceutical, agrochemical, and materials science
Potential Therapeutic Uses
Ongoing scientific study and research
Chemical Stability
Unknown
Solubility
Unknown
Reactivity
Unknown
Toxicity
Unknown
Check Digit Verification of cas no
The CAS Registry Mumber 2562-68-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,5,6 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2562-68:
(6*2)+(5*5)+(4*6)+(3*2)+(2*6)+(1*8)=87
87 % 10 = 7
So 2562-68-7 is a valid CAS Registry Number.
2562-68-7Relevant articles and documents
Tuning the photophysical and electrochemical properties of iridium(III) 2-aryl-1-phenylbenzimidazole complexes
Bezzubov, Stanislav I.,Doljenko, Vladimir D.,Troyanov, Sergey I.,Kiselev, Yuri M.
, p. 22 - 30 (2014/04/17)
A series of heteroleptic bis-cyclometalated iridium(III) complexes, [Ir(cpbi)2(H2dcbpy)][PF6] (1), [Ir(pbi) 2(H2dcbpy)][PF6] (2), and [Ir(mpbi) 2(H2dcbpy)][PF6] (3), where pbi = 1,2-diphenylbenzimidazole, cpbi = 2-(4-chlorophenyl)-1-phenylbenzimidazole, mpbi = 2-(3,4-dimethoxyphenyl)-1-phenylbenzimidazole, and H2dcbpy = 2,2′-bipyridine-4,4′-dicarboxylic acid has been synthesized and characterized by elemental analysis, 1H, 31P NMR, and high resolution mass-spectra. Molecular structure of complex 3 has been determined from single-crystal X-ray analysis. The complexes exhibit absorption up to 550 nm with molar absorptivities of 2500 M-1 cm-1. They have strong luminescence in broad yellow-to-red region in solutions at room temperature. While chloro-substituent (complex 1) causes a little hypsochromic shift of the absorption maxima compared to unsubstituted 2, introduction of two methoxy-groups (complex 3) gives rise to a bathochromic shift of about 100 nm. Alternating current voltammetry studies of the complexes indicates reversible oxidation and reduction potentials. Calculated excited state oxidation potentials for 1-3 are negative enough to efficiently inject electrons into the conduction band of TiO2 (EF). 2014 Elsevier B.V. All rights reserved.
Synthesis and β-glucuronidase inhibitory potential of benzimidazole derivatives
Khan, Khalid Mohammed,Khan, Momin,Ambreen, Nida,Rahim, Fazal,Naureen, Shagufta,Perveen, Shahnaz,Choudhary, M. Iqbal,Voelterc, Wolfgang
body text, p. 421 - 427 (2012/09/05)
Benzimidazole derivatives 1-24 have been synthesized and their in vitro β-glucuronidase inhibitory activitiy was evaluated. Compounds 15 (IC 50 = 6.33 ± 0.40 μM), 7 (IC50 = 22.0 ± 0.33 μM), 2 (IC50 = 23.1 ± 1.78 μM), 17 (I
Methods of treating or preventing sleep apnea
-
, (2008/06/13)
This invention provides methods for the treatment or prevention of sleep apnea in a mammal which compris administering to a mammal in need thereof an effective amount of a substituted benzimidazole, or a pharmaceutically acceptable salt or solvate thereof.
